Received Jun 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
adverse reaction that consisted of a uh severe rash all throughout her body; This spontaneous report has been received from a healthcare professional regarding a female patient of unknown age. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), administered as prophylaxis (strength, dose, vaccination scheme, route of administration, anatomical site of injection, lot number, and expiration date were not reported). On an unknown date, the patient experienced an adverse reaction that consisted of a severe rash all throughout her body (Rash). On an unknown date, the patient recovered from the event. The reporter considered the event of rash to be related to Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9).